30.93
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRNA Giù?
Forum
Previsione
Precedente Chiudi:
$31.87
Aprire:
$31.52
Volume 24 ore:
10.03M
Relative Volume:
0.97
Capitalizzazione di mercato:
$11.90B
Reddito:
$5.06B
Utile/perdita netta:
$-2.22B
Rapporto P/E:
-5.3144
EPS:
-5.82
Flusso di cassa netto:
$-3.96B
1 W Prestazione:
-9.48%
1M Prestazione:
-26.79%
6M Prestazione:
-63.58%
1 anno Prestazione:
-64.62%
Moderna Inc Stock (MRNA) Company Profile
Nome
Moderna Inc
Settore
Industria
Telefono
(617) 714-6500
Indirizzo
325 BINNEY STREET, CAMBRIDGE
Confronta MRNA con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
MRNA
Moderna Inc
|
30.93 | 11.90B | 5.06B | -2.22B | -3.96B | -5.82 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
455.22 | 117.23B | 10.63B | -479.80M | -1.35B | -1.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
665.46 | 72.75B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
636.02 | 38.65B | 1.86B | -40.29M | -1.28B | -0.85 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
268.99 | 34.69B | 2.09B | -332.26M | 16.06M | -2.62 |
![]()
BNTX
Biontech Se Adr
|
114.50 | 27.45B | 3.30B | -501.07M | 1.03B | -2.1146 |
Moderna Inc Stock (MRNA) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-01-29 | Downgrade | Goldman | Buy → Neutral |
2024-12-18 | Downgrade | Argus | Buy → Hold |
2024-12-10 | Ripresa | BofA Securities | Underperform |
2024-11-19 | Iniziato | Berenberg | Hold |
2024-11-18 | Aggiornamento | HSBC Securities | Hold → Buy |
2024-11-15 | Iniziato | Wolfe Research | Underperform |
2024-10-17 | Iniziato | Bernstein | Mkt Perform |
2024-09-13 | Downgrade | JP Morgan | Neutral → Underweight |
2024-09-13 | Downgrade | Jefferies | Buy → Hold |
2024-09-13 | Downgrade | Oppenheimer | Outperform → Perform |
2024-08-28 | Aggiornamento | HSBC Securities | Reduce → Hold |
2024-08-07 | Aggiornamento | Deutsche Bank | Sell → Hold |
2024-08-05 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
2024-02-26 | Downgrade | HSBC Securities | Hold → Reduce |
2024-01-02 | Aggiornamento | Oppenheimer | Perform → Outperform |
2023-11-29 | Iniziato | Canaccord Genuity | Hold |
2023-11-03 | Aggiornamento | HSBC Securities | Reduce → Hold |
2023-11-02 | Downgrade | Deutsche Bank | Hold → Sell |
2023-08-04 | Downgrade | TD Cowen | Outperform → Market Perform |
2023-08-03 | Downgrade | Deutsche Bank | Buy → Hold |
2023-07-24 | Iniziato | William Blair | Mkt Perform |
2023-07-14 | Iniziato | HSBC Securities | Reduce |
2023-06-26 | Aggiornamento | UBS | Neutral → Buy |
2023-04-26 | Iniziato | Guggenheim | Neutral |
2023-03-13 | Aggiornamento | TD Cowen | Market Perform → Outperform |
2023-03-02 | Iniziato | RBC Capital Mkts | Outperform |
2023-02-24 | Downgrade | SVB Securities | Market Perform → Underperform |
2022-12-19 | Aggiornamento | Jefferies | Hold → Buy |
2022-12-14 | Downgrade | Chardan Capital Markets | Buy → Neutral |
2022-10-21 | Aggiornamento | SVB Leerink | Underperform → Mkt Perform |
2022-09-08 | Aggiornamento | Deutsche Bank | Hold → Buy |
2022-02-01 | Aggiornamento | Redburn | Sell → Neutral |
2022-01-26 | Aggiornamento | Deutsche Bank | Sell → Hold |
2022-01-21 | Aggiornamento | BofA Securities | Underperform → Neutral |
2022-01-21 | Iniziato | UBS | Neutral |
2021-12-07 | Iniziato | Cowen | Market Perform |
2021-11-09 | Iniziato | Wolfe Research | Outperform |
2021-10-22 | Iniziato | Deutsche Bank | Sell |
2021-10-15 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2021-08-06 | Downgrade | Oppenheimer | Outperform → Perform |
2021-08-06 | Downgrade | Piper Sandler | Overweight → Neutral |
2021-07-15 | Reiterato | Jefferies | Hold |
2021-02-01 | Downgrade | BofA Securities | Neutral → Underperform |
2020-12-16 | Downgrade | Jefferies | Buy → Hold |
2020-12-16 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2020-12-09 | Downgrade | Needham | Buy → Hold |
2020-11-23 | Iniziato | Wells Fargo | Equal Weight |
2020-11-17 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
2020-09-08 | Downgrade | SVB Leerink | Mkt Perform → Underperform |
2020-07-23 | Iniziato | SVB Leerink | Mkt Perform |
2020-07-20 | Downgrade | JP Morgan | Overweight → Neutral |
2020-07-13 | Iniziato | Jefferies | Buy |
2020-06-30 | Iniziato | Argus | Buy |
2020-06-08 | Iniziato | Barclays | Overweight |
2020-04-30 | Iniziato | BMO Capital Markets | Outperform |
2020-03-05 | Downgrade | BofA/Merrill | Buy → Neutral |
2019-12-03 | Ripresa | BofA/Merrill | Buy |
2019-10-25 | Iniziato | ROTH Capital | Buy |
2019-04-05 | Iniziato | Chardan Capital Markets | Buy |
Mostra tutto
Moderna Inc Borsa (MRNA) Ultime notizie
Could Moderna’s (MRNA) 65% Stock Plunge Entice a Takeover? - Markets Insider
Analysts recommendations: Gsk, Halma, Bellway, On Holding, Moderna… - Marketscreener.com
Analysts recommendations: Lyft, Coty, Upstart, On Holding, Moderna... - Marketscreener.com
Moderna (MRNA) Projected to Post Quarterly Earnings on Friday - MarketBeat
Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Bank of America Issues Pessimistic Forecast for Moderna (NASDAQ:MRNA) Stock Price - MarketBeat
abrdn plc Purchases 69,360 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
What the Options Market Tells Us About Moderna - Benzinga
Moderna stock target cut at BofA as key challenges persist By Investing.com - Investing.com Nigeria
BofA Securities Cuts Moderna Price Target to $34 From $41, Maintains Underperform Rating - Marketscreener.com
Bank of America Cuts Moderna (NASDAQ:MRNA) Price Target to $34.00 - MarketBeat
Moderna Stock: A Deep Dive Into Analyst Perspectives (11 Ratings) - Benzinga
Moderna’s Underperform Rating: Challenges in Revenue Diversification and Forecasting Amid Pandemic Volatility - TipRanks
Why Moderna Inc. (MRNA) Crashed Last Week - MSN
Mirae Asset Global Investments Co. Ltd. Trims Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
US Not Liable In Moderna Covid-19 Vaccine Patent Case: Second Judge - BW Healthcare World
Taiwan Approves Omicron-targeted Moderna Covid Vaccine - BW Healthcare World
Moderna (MRNA) Projected to Post Earnings on Friday - MarketBeat
Quattro Financial Advisors LLC Raises Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Deadly Bird Flu Strain Detected In Nevada Man: 4 Stocks To Watch - Benzinga
Stock Showdown: Why Robinhood is a Buy and Moderna is Tumbling! - Jomfruland.net
1 Stock to Buy, 1 Stock to Sell This Week: Robinhood, Moderna - Yahoo Finance
Estee Lauder, Moderna And PayPal Are Among Top 10 Large Cap Losers Last Week (Feb 3-Feb 7): Are The Others In Your Portfolio? - Benzinga
Moderna (NASDAQ:MRNA) Shares Down 4.7%What's Next? - MarketBeat
Why Moderna, Inc. (MRNA) Is Among the Best Healthcare Stocks To Buy According to Analysts - Insider Monkey
Spire Wealth Management Increases Stake in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Robeco Institutional Asset Management B.V. Has $1.33 Million Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
No, Moderna Did Not Create Its COVID Vaccine Two Years Before the Pandemic - Yahoo
Moderna Inc Testing Potential Monkeypox Vaccines - BW Healthcare World
Do Wall Street Analysts Like Moderna Stock? - MSN
Moderna (MRNA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release - Yahoo Finance
Moderna Poised to Report Q4 Earnings: Is a Beat in the Cards? - Yahoo Finance
Moderna (NASDAQ:MRNA) Trading Down 4.7%Here's Why - MarketBeat
Pacer Advisors Inc. Sells 20,901 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna Dropped by 20% This Week -- Is It a Smart Buy Right Now? - AOL
Is Moderna Stock A Sell With Robert F. Kennedy Eyeing The Lead Role At HHS? - Yahoo
KBC Group NV Sells 38,943 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Sell Rating for Moderna Amid Regulatory Concerns and Stock Volatility - TipRanks
Swedbank AB Boosts Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Everett Harris & Co. CA Invests $275,000 in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Why Moderna, Inc. (MRNA) Went Down on Tuesday - MSN
MRNA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Moderna, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Why Moderna Inc. (MRNA) Crashed on Monday - MSN
Moderna call volume above normal and directionally bullish - TipRanks
Global mRNA Vaccines and Therapeutics Market is expected - openPR
Moderna and BioNTech shares fall after Senate committee vote RFK Jr. - Investing.com Canada
This Is What Whales Are Betting On Moderna - Benzinga
Moderna Inc Azioni (MRNA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):